Stephen Aradi, MD
Neurology
Penn Neurology Pennsylvania Hospital
View 1 additional location
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Neurology

Education and training

  • Residency: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Aradi is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Vaillancourt DE, Barmpoutis A, Wu SS, DeSimone JC, Schauder M, Chen R, Parrish TB, Wang WE, Molho E, Morgan JC, Simon DK, Scott BL, Rosenthal LS, Gomperts SN, Akhtar RS, Grimes D, De Jesus S, Stover N, Bayram E, Ramirez-Zamora A, Prokop S, Fang R, Slevin JT, Kanel P, Bohnen NI, Tuite P, Aradi S, Strafella AP, Siddiqui MS, Davis AA, Huang X, Ostrem JL, Fernandez H, Litvan I, Hauser RA, Pantelyat A, McFarland NR, Xie T, Okun MS; AIDP Study Group; Leader A, Russell Á, Babcock H, White-Tong K, Hua J, Goodheart AE, Peterec EC, Poon C, Galarce MB, Thompson T, Collier AM, Cromer C, Putra N, Costello R, Yilmaz E, Mercado C, Mercado T, Fessenden A, Wagner R, Spears CC, Caswell JL, Bryants M, Kuzianik K, Ahmed Y, Bendahan N, Njoku JO, Stiebel A, Zahed H, Wang SS, Hoang PT, Seemiller J, Du G Automated Imaging Differentiation for Parkinsonism , JAMA Neurol, 82(5): 2025,495-505


Aradi S, Hauser RA. Current use of neurotoxins for alleviating symptoms of cervical dystonia , Expert Rev Neurother, 24(8): 2024,787-797


Song W, Daneman L, Cohen-Oram A, Aradi S A Case Series of Delusional Infestation in Huntington's Disease , J Huntingtons Dis, 13(3): 2024,399-401


McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, Zhou J, Schlegel V, Sanwald Ducray P, Hawellek DJ, Dorn J, Simillion C, Lindemann M, Wheelock V, Durr A, Anderson KE, Long JD, Wild EJ, Landwehrmeyer GB, Leavitt BR, Tabrizi SJ, Doody R Tominersen in Adults with Manifest Huntington's Disease , N Engl J Med, 389(23): 2023 ,2203-2205


Jiang RY, Aradi S. F198S Gerstmann-Sträussler-Scheinker Syndrome With Parkinsonism, Dyskinesia, and Abnormal (I-123)-FP-CIT Single-Photon Emission Computed Tomography: A Case Report , Cureus, 15(12): 2023,e50594


McLean L, Aradi S, Waknin R, Rea B, Camacho MA HIV-associated dementia presenting predominantly with clinical motor deficits: A case report , Radiol Case Rep, 17(9): 2022,3005-3008


Scheid BH, Aradi S, Pierson RM, Baldassano S, Tivon I, Litt B, Gonzalez-Alegre P Predicting Severity of Huntington's Disease With Wearable Sensors , Front Digit Health, 4: 2022,874208


Jenner P, Mori A, Aradi SD, Hauser RA. Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease , Expert Rev Neurother, 21(3): 2021,317-333


Aradi S, Cucchiara BL Chapter 24: Dysarthria , Decision-Making in Adult Neurology: 2021,48-49


LeWitt PA, Aradi SD, Hauser RA, Rascol O. The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant , Parkinsonism Relat Disord, 80(Suppl 1): 2020,S54-S63